Same-day Strattera appointment in New York

If you’ve been struggling with ADHD symptoms—difficulty focusing at work, losing track of conversations, or feeling overwhelmed by everyday tasks—you might be wondering whether telehealth can help you access treatment. The short answer is yes, especially when it comes to non-stimulant ADHD medications like Strattera (atomoxetine).

Unlike stimulant medications such as Adderall or Vyvanse, non-stimulant ADHD medications aren’t classified as controlled substances by the DEA. This distinction makes them significantly more accessible through telehealth platforms, with fewer regulatory hurdles and greater prescribing flexibility across all 50 states.

In this comprehensive guide, we’ll walk you through everything you need to know about getting ADHD non-stimulant medications via telehealth—from federal and state regulations to what you can expect during your virtual appointment.

Understanding Non-Stimulant ADHD Medications

What Makes Non-Stimulants Different?

Non-stimulant ADHD medications work differently than their stimulant counterparts. The most commonly prescribed non-stimulant is Strattera (atomoxetine), which is a selective norepinephrine reuptake inhibitor (NRI). Unlike stimulants that provide rapid symptom relief within 30-60 minutes, Strattera typically takes 4-6 weeks to reach full effectiveness.

Key advantages of non-stimulants include:

• Not controlled substances – Strattera carries no DEA schedule classification, meaning no risk of dependency or abuse potential
• Longer prescription periods – Healthcare providers can prescribe 90-day supplies with multiple refills, unlike the 30-day limit on stimulants
• No special refill restrictions – You won’t need a new prescription each month
• 24-hour symptom coverage – Effects last throughout the day and night
• Lower abuse potential – Safe option for individuals with substance use history

Who Benefits Most from Non-Stimulant ADHD Treatment?

Non-stimulant medications may be the better choice if you:

• Have a history of substance abuse or addiction concerns
• Experience anxiety, tics, or sleep problems worsened by stimulants
• Have certain heart conditions or high blood pressure
• Prefer avoiding the ‘ups and downs’ of stimulant medications
• Need consistent 24/7 symptom management
• Haven’t responded well to stimulant medications

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Rules for ADHD Medications

Current DEA Status (As of December 2025)

The regulatory landscape for telehealth ADHD treatment has been evolving rapidly since the COVID-19 pandemic. Here’s what you need to know:

For Non-Stimulant Medications (Like Strattera):

• No federal restrictions on telehealth prescribing
• No in-person exam required by DEA regulations
• The Ryan Haight Act’s in-person requirement applies only to controlled substances—Strattera is exempt
• Licensed providers can prescribe after a comprehensive telehealth evaluation

For Stimulant Medications (Schedule II controlled substances):

• Temporary telehealth flexibilities currently extended through December 31, 2025
• These COVID-era waivers allow prescribing without a prior in-person exam
• A fourth extension for 2026 is anticipated but not yet finalized
• If waivers expire without replacement, the Ryan Haight Act’s in-person exam requirement could resume

What This Means for You

If you’re seeking Strattera or other non-stimulant ADHD medications, you can access care entirely through telehealth with no federal mandates for in-person visits. The regulatory uncertainty primarily affects stimulant prescriptions, not non-controlled ADHD treatments.

For patients already established on stimulant medications through telehealth, many providers are preparing contingency plans should regulations change in 2026. Reputable telehealth platforms like Klarity Health monitor these developments closely to ensure uninterrupted care for their patients.

State-by-State Telehealth Rules for ADHD Treatment

While federal law sets the baseline, state regulations vary significantly. Here’s what you need to know about telehealth ADHD treatment in major states:

California: Telehealth-Friendly with Clear Standards

Telehealth Allowed: Yes, for both stimulant and non-stimulant ADHD medications
In-Person Requirements: None for non-controlled medications
Prescriber Authority: Nurse practitioners can practice independently after meeting AB 890 requirements

California has embraced telehealth broadly. For Strattera and other non-stimulants, providers simply need to establish a proper provider-patient relationship through video consultation and meet the standard of care. California law defines a telehealth exam as satisfying the ‘good faith exam’ requirement for prescribing.

A pending bill (AB 1503) may further clarify that telehealth evaluations fully count as prior exams for prescription purposes, though this hasn’t affected current practice.

New York: Stricter Rules for Controlled Substances

Telehealth Allowed: Yes, but with important distinctions
In-Person Requirements: Required initially for controlled substances only (as of May 2025)
Non-Stimulant Status: No in-person requirement for Strattera
Prescriber Authority: NPs can practice independently after 3,600 supervised hours

New York implemented stricter telehealth rules in 2025, requiring an initial in-person evaluation before prescribing any controlled substance via telemedicine. However, this rule does not apply to Strattera since it’s not a controlled medication.

For New York residents seeking non-stimulant ADHD treatment, telehealth remains fully accessible without in-person visits. Providers must check the state’s Prescription Monitoring Program (PMP) for controlled substances, though this isn’t legally required for Strattera.

Florida: Psychiatric Exception Allows Flexibility

Telehealth Allowed: Yes, with psychiatric disorder exception
In-Person Requirements: None for non-controlled medications
Schedule II Rules: Telehealth prescribing allowed for psychiatric conditions (ADHD qualifies)
Prescriber Authority: NPs/PAs require physician collaboration; limited Schedule II authority

Florida law generally prohibits telehealth prescribing of Schedule II stimulants—except when treating a psychiatric disorder. Since ADHD is classified as a psychiatric condition, both stimulant and non-stimulant medications can be prescribed via telehealth in Florida.

For Strattera specifically, there are no special restrictions. Florida requires providers to check the Prescription Drug Monitoring Program before every controlled substance prescription, though this doesn’t apply to non-controlled medications.

Texas: Mental Health-Friendly Telehealth Laws

Telehealth Allowed: Yes, especially for mental health treatment
In-Person Requirements: None for ADHD treatment
Prescriber Limitations: NPs/PAs cannot prescribe Schedule II outside hospital/hospice settings
PMP Requirements: Mandated for opioids/benzodiazepines, recommended for stimulants

Texas has been progressive with telehealth for behavioral health conditions. The state specifically allows telemedicine for mental health care without in-person requirements. While Texas does restrict certain controlled substance prescriptions without in-person visits (particularly for chronic pain), ADHD treatment is explicitly permitted via telehealth.

For non-stimulant medications, Texas places no special restrictions. However, nurse practitioners and physician assistants face significant limitations on Schedule II prescribing—they can only prescribe stimulants in hospital or hospice settings, not regular outpatient care.

Alabama: Among the Strictest State Requirements

Telehealth Allowed: Yes, but with periodic in-person requirements
In-Person Requirements: Within 12 months for ongoing treatment (mental health services exempt)
Special Rules: Licensed medical personnel must be physically present with patient for controlled substance telehealth
Prescriber Authority: Collaborative practice; NPs/PAs can obtain special credentials for controlled substances

Alabama maintains some of the nation’s strictest telehealth regulations. After four telehealth visits for the same condition, patients must have an in-person evaluation within 12 months—unless receiving mental health services, which are exempt from this rule.

For ADHD treatment classified as mental health care, the 12-month requirement may not apply. However, Alabama’s requirement that a nurse or other medical professional be physically present during telehealth visits for controlled substance prescriptions creates practical barriers for some patients.

These restrictions don’t affect Strattera prescribing, which can proceed via standard telehealth without the presence requirement.

New Hampshire: Recently Expanded Access

Telehealth Allowed: Yes, with new flexibilities as of August 2025
In-Person Requirements: Annual follow-up evaluation required (can be via telehealth)
Recent Changes: Removed prior in-person mandate in 2025
Prescriber Authority: Independent NP practice allowed

New Hampshire significantly expanded telehealth access in 2025 by passing SB 252, which removed the initial in-person examination requirement. Now, providers must conduct at least an annual follow-up evaluation when prescribing controlled medications via telemedicine—but this evaluation can itself be conducted through telehealth.

This change made New Hampshire one of the more progressive states for ADHD telehealth treatment. For non-stimulant medications, there are no special requirements beyond standard medical practice.

Other State Considerations

Pennsylvania: No in-person mandates; collaborative practice for NPs/PAs; PDMP checks required before first opioid/benzodiazepine prescription

Illinois: Full practice authority for experienced NPs; no telehealth-specific restrictions; PDMP checks required for Schedule II narcotics

Georgia: No in-person requirements; NPs cannot prescribe Schedule II independently; PDMP check at first controlled prescription and every 90 days

What to Expect from Your Telehealth ADHD Evaluation

The Comprehensive Assessment Process

Reputable telehealth providers conduct thorough evaluations that match—and often exceed—the depth of traditional in-person appointments. Here’s what a legitimate ADHD assessment involves:

1. Detailed Symptom HistoryYour provider will ask about ADHD symptoms in multiple life areas:

• Work or school performance difficulties
• Relationship and social challenges
• Time management and organizational struggles
• Impulsivity or hyperactivity patterns
• Childhood symptom onset (ADHD must be present before age 12 for diagnosis)

2. DSM-5 Diagnostic Criteria ReviewProviders use standardized diagnostic criteria requiring:

• Six or more symptoms of inattention and/or hyperactivity-impulsivity
• Symptoms present for at least 6 months
• Symptoms interfering with functioning in multiple settings
• Evidence symptoms were present before age 12
• Symptoms not better explained by another mental health condition

3. Rating Scales and QuestionnairesYou may complete validated assessment tools such as:

• Adult ADHD Self-Report Scale (ASRS)
• Conners’ Adult ADHD Rating Scales
• Childhood behavior questionnaires
• Functional impairment measures

4. Medical History and Safety ScreeningExpect questions about:

• Current medications and supplements
• Past mental health diagnoses and treatment
• Cardiovascular health (blood pressure, heart conditions)
• Substance use history
• Family psychiatric history
• Previous ADHD medication trials

5. Contraindication Assessment for StratteraYour provider will screen for conditions that make Strattera unsafe:

• Narrow-angle glaucoma
• Current or recent MAOI antidepressant use (within 14 days)
• Severe cardiovascular disorders
• Liver disease or elevated liver enzymes
• History of severe allergic reactions to atomoxetine

Documentation You May Need to Provide

To support your evaluation, gather:

• Previous ADHD diagnoses or evaluations (if available)
• School records showing childhood difficulties (report cards, IEPs)
• Work performance reviews noting attention issues
• Current medication list
• Medical records from other providers
• Completed pre-appointment questionnaires

Don’t worry if you lack formal documentation. Many adults were never diagnosed in childhood. Providers can diagnose ADHD in adults based on current comprehensive assessment and retrospective childhood history.

Red Flags: When Telehealth Isn’t Appropriate

Legitimate providers will decline or defer telehealth ADHD treatment in certain situations:

• Acute psychiatric crisis requiring immediate in-person intervention
• Uncontrolled bipolar disorder or psychosis (needs stabilization first)
• Severe substance use disorder requiring specialized treatment
• Serious unstable medical conditions (uncontrolled hypertension, recent cardiac events)
• Request for early refills or dose escalation suggesting misuse
• Unwillingness to consent to care coordination with other providers

If a telehealth provider seems too eager to prescribe without thorough evaluation, or guarantees medication before assessment—that’s a major warning sign. Run, don’t walk, away from such services.

How Klarity Health Approaches ADHD Telehealth Care

At Klarity Health, we’ve designed our ADHD treatment program around evidence-based practices and patient safety. Here’s what sets our approach apart:

Licensed Providers in Your State

Every Klarity provider is licensed in your specific state and maintains appropriate DEA registration when needed. Whether you see an MD, DO, or nurse practitioner, you’re receiving care from a qualified professional authorized to practice in your location.

Comprehensive Diagnostic Process

Our initial ADHD evaluations typically last 60-90 minutes and include:

• Structured clinical interview based on DSM-5 criteria
• Validated ADHD rating scales
• Review of developmental and medical history
• Discussion of treatment options (medication and non-medication approaches)
• Personalized treatment planning

Transparent Pricing for Everyone

We believe quality ADHD care should be accessible, which is why Klarity offers:

• Insurance acceptance for most major plans—we handle the billing complexity so you don’t have to
• Cash-pay options with upfront, transparent pricing (no surprise bills)
• Flexible payment plans to fit your budget
• No hidden fees for prescription refills or brief follow-up questions

Exceptional Provider Availability

Unlike traditional psychiatry where wait times can stretch months, Klarity typically offers:

• Appointments within days, not weeks or months
• Flexible scheduling including evenings and weekends
• Easy rescheduling through our patient portal
• Quick follow-ups to adjust treatment as needed

Ongoing Support and Monitoring

ADHD treatment isn’t ‘prescribe and forget.’ Our providers schedule regular check-ins to:

• Monitor medication effectiveness and side effects
• Adjust dosing as needed
• Screen for emerging concerns
• Provide education about ADHD management strategies
• Coordinate with your other healthcare providers when beneficial

Non-Stimulant ADHD Medications: Beyond Strattera

While Strattera is the most common non-stimulant ADHD medication, other options exist:

Strattera (Atomoxetine)

How it works: Selective norepinephrine reuptake inhibitor
Typical dosing: Starting at 40mg daily, adjusted to 80-100mg
Time to effect: 4-6 weeks for full benefits
Advantages: Once-daily dosing, no abuse potential, 24-hour coverage
Common side effects: Decreased appetite, upset stomach, drowsiness (initially), slight blood pressure increases

Qelbree (Viloxazine)

How it works: Norepinephrine reuptake inhibitor with additional mechanisms
FDA approval: 2021 for ages 6 and up
Typical dosing: Starting at 100-200mg, adjusted up to 600mg
Advantages: Non-controlled, once-daily, newer option with different side effect profile than Strattera
Common side effects: Drowsiness, decreased appetite, fatigue, insomnia

Intuniv (Guanfacine Extended-Release)

How it works: Alpha-2A adrenergic receptor agonist
Originally: Blood pressure medication, now FDA-approved for ADHD
Typical dosing: 1-4mg once daily
Advantages: Can help with hyperactivity and impulsivity; may reduce tics
Common side effects: Drowsiness, fatigue, low blood pressure, headache

Kapvay (Clonidine Extended-Release)

How it works: Alpha-2 adrenergic agonist
Typical dosing: 0.1-0.4mg daily
Best for: Hyperactivity, impulsivity, and sleep issues
Common side effects: Drowsiness, dry mouth, constipation, dizziness

Wellbutrin (Bupropion) – Off-Label

How it works: Norepinephrine-dopamine reuptake inhibitor (antidepressant)
ADHD status: Not FDA-approved but commonly prescribed off-label
Advantages: Also treats depression; some find it activating/helpful for focus
Common side effects: Dry mouth, headache, insomnia, anxiety

Your provider will discuss which option makes the most sense based on your specific symptoms, medical history, and lifestyle needs.

Comparing Non-Stimulant vs. Stimulant ADHD Treatment via Telehealth

Practical Tips for Successful ADHD Telehealth Treatment

Before Your Appointment

1. Choose a Quiet, Private SpaceFind a location where you can speak freely without interruptions. Good lighting and a stable internet connection are essential.

2. Test Your TechnologyEnsure your device’s camera and microphone work properly. Download any required apps or access the video platform beforehand.

3. Prepare Your Medical HistoryWrite down:

• Current and past medications
• Medical conditions and surgeries
• Family history of ADHD or mental health conditions
• Questions you want to ask

4. Document Your SymptomsKeep a symptom journal for a week before your appointment, noting:

• When symptoms are worst
• How they affect work, relationships, daily tasks
• Strategies you’ve tried
• Specific examples of impairment

5. Have Insurance Information ReadyIf using insurance, have your card accessible and verify Klarity is in-network (we accept most major plans).

During Your Evaluation

Be Honest and ThoroughYour provider relies on your reported history since they can’t physically examine you. Mention:

• All substances you use (including alcohol, cannabis, tobacco)
• Mental health symptoms beyond ADHD
• Previous medication trials (what worked, what didn’t)
• Any history of misusing medications

Ask QuestionsThis is your opportunity to understand:

• Why a particular medication is recommended
• Expected timeline for improvement
• What side effects to watch for
• How to reach the provider if problems arise
• Non-medication strategies that might help

Discuss Your Preferences and ConcernsTell your provider:

• If you prefer avoiding controlled substances
• Whether cost is a major factor
• If you have specific concerns about side effects
• Your work or school schedule (affects dosing timing)

After Your Appointment

1. Understand Your Treatment PlanMake sure you know:

• How and when to take your medication
• What improvements to expect and when
• Warning signs that require immediate contact
• When your follow-up is scheduled

2. Monitor Your ResponseKeep track of:

• Symptom improvements in different settings
• Any side effects (even minor ones)
• Changes in sleep, appetite, mood
• Blood pressure if requested

3. Attend Follow-Up AppointmentsRegular monitoring is crucial, especially when:

• Starting a new medication
• Adjusting doses
• First three months of treatment
• Any concerns arise

4. Communicate ProactivelyDon’t wait for your next appointment if you experience:

• Severe side effects
• No improvement after expected timeframe
• Worsening symptoms
• Questions about your medication

5. Refill Medications on TimeFor Strattera and non-stimulants:

• Request refills a week before running out
• Account for pharmacy processing time
• Some pharmacies may need to order less common medications

Common Misconceptions About Telehealth ADHD Treatment

‘Online ADHD Prescriptions Are Automatic’

Reality: Legitimate telehealth providers follow the same rigorous diagnostic standards as in-person care. A comprehensive ADHD evaluation examines symptoms across multiple domains, developmental history, and alternative explanations. Any service that ‘guarantees’ medication before evaluation is a red flag and likely operating illegally.

‘Telehealth Doctors Can’t Prescribe Controlled Medications’

Reality: Under current federal rules (extended through December 2025), qualified telehealth providers with DEA registration can prescribe Schedule II-V controlled substances, including ADHD stimulants. This is legal and widely practiced. For non-controlled medications like Strattera, there have never been federal telehealth restrictions.

‘Non-Stimulants Don’t Really Work for ADHD’

Reality: While stimulants work for about 70-80% of ADHD patients, non-stimulants are highly effective for many people—particularly those who:

• Can’t tolerate stimulant side effects
• Have anxiety worsened by stimulants
• Prefer 24-hour symptom control
• Have substance use concerns

Clinical studies show Strattera produces significant symptom improvement in approximately 60-70% of patients. It may take longer to work, but many find the steady, consistent effect preferable to the ‘on-off’ nature of stimulants.

‘Local Pharmacies Won’t Fill Telehealth Prescriptions’

Reality: Most pharmacies readily fill prescriptions from licensed telehealth providers. Electronic prescriptions don’t indicate whether your visit was virtual or in-person. Some pharmacies in 2023 increased scrutiny of stimulant prescriptions from certain controversial telehealth companies, but this affected a small percentage of legitimate prescriptions.

For Strattera, you should expect no issues—it’s not a controlled substance and raises no red flags.

‘Telehealth ADHD Treatment Is Lower Quality’

Reality: Research shows telehealth psychiatry achieves comparable outcomes to in-person care for most patients. Many people actually prefer telehealth because:

• Reduced anxiety about in-office visits
• No time lost to commute and waiting rooms
• Easier to maintain consistency in busy schedules
• Ability to see specialists not locally available

Quality depends on the provider and platform, not the modality. Klarity’s providers undergo the same training and maintain the same standards whether seeing patients virtually or in person.

The Regulatory Landscape: What’s Coming in 2026?

Current Status and Expected Changes

The DEA’s temporary telehealth flexibilities for controlled substances are set to expire on December 31, 2025. Here’s what we know:

Most Likely Scenario:A fourth extension into 2026 is in Office of Management and Budget (OMB) review and widely expected to be finalized. This would maintain current prescribing flexibility for stimulant ADHD medications.

If No Extension Passes:The Ryan Haight Act’s original requirements would resume, meaning:

• Initial in-person medical evaluation required before prescribing any controlled substance via telehealth
• Patients already established on treatment might be grandfathered
• Providers would need to coordinate with local clinicians for in-person exams

Long-Term Outlook:The DEA has proposed a ‘Special Registration’ system for permanent telehealth prescribing authority with additional safeguards. While not yet finalized, this could provide a stable framework by 2026-2027.

What This Means for Strattera and Non-Stimulants

No change expected. Since Strattera isn’t a controlled substance, DEA regulations don’t affect its telehealth prescribing. Regardless of what happens with stimulant medication rules, non-stimulant ADHD treatment via telehealth will remain fully accessible.

How Klarity Prepares for Regulatory Changes

At Klarity Health, we closely monitor federal and state regulations to ensure uninterrupted patient care:

• Proactive patient communication about any policy changes
• Coordination with local providers if in-person exams become required
• Hybrid care models combining telehealth and in-person visits when needed
• State-specific compliance for varying requirements
• Multiple treatment options including non-controlled medications as alternatives

Our goal is ensuring you have continuous access to ADHD treatment regardless of regulatory shifts.

Insurance, Costs, and Affordability

Insurance Coverage for Telehealth ADHD Treatment

Good news: Most insurance plans now cover telehealth mental health visits at the same rate as in-person appointments. This includes:

• Diagnostic evaluations
• Follow-up medication management
• Therapy/counseling sessions

At Klarity Health, we accept most major insurance plans including:

• Blue Cross Blue Shield
• Aetna
• Cigna
• UnitedHealthcare
• Medicare (in many states)
• Medicaid (where telehealth is covered)

We handle the billing process, so you simply pay your copay or coinsurance amount.

Self-Pay Options

For those without insurance or who prefer cash payment, Klarity offers transparent, affordable pricing:

• Initial ADHD evaluation: Competitive flat-rate fee (no surprise charges)
• Follow-up appointments: Lower rate for medication management visits
• No hidden fees for prescription refills or portal messages
• Payment plans available for those who need them

Our cash rates are often comparable to insurance copays and far less than traditional out-of-network psychiatric care.

Medication Costs

Strattera pricing varies based on:

• Generic vs. brand-name (generic atomoxetine is significantly cheaper)
• Insurance formulary tier
• Pharmacy choice (compare prices at different pharmacies)
• Discount programs and coupons

Cost-saving strategies:

1. Ask for generic atomoxetine – Usually $30-100/month vs. $300+ for brand Strattera
2. Use prescription discount cards – GoodRx, SingleCare, or pharmacy loyalty programs
3. Shop different pharmacies – Prices can vary dramatically between chains
4. Request 90-day supplies – Often cheaper per month than 30-day fills
5. Check manufacturer coupons – Lilly (Strattera’s maker) sometimes offers copay cards

Frequently Asked Questions

Can I get an initial ADHD diagnosis via telehealth?

Yes. Qualified providers can diagnose ADHD through comprehensive telehealth evaluations using DSM-5 criteria, clinical interviews, rating scales, and developmental history. Many adults are first diagnosed via telehealth.

Do I need to have been diagnosed with ADHD as a child?

No. While ADHD symptoms must have been present in childhood (before age 12), a formal childhood diagnosis isn’t required. Many people—especially women—weren’t diagnosed until adulthood despite having clear childhood symptoms. Your provider will gather retrospective history to establish early symptom onset.

How long does Strattera take to work?

Most people begin noticing improvements within 1-2 weeks, but full therapeutic effects typically take 4-6 weeks. Unlike stimulants which work immediately, Strattera builds up in your system over time. Don’t give up if you don’t feel different in the first week.

What if Strattera doesn’t work for me?

Your provider has multiple options:

• Adjust the dosage (often goes up to 100mg or higher)
• Switch to a different non-stimulant (Qelbree, Intuniv, Wellbutrin)
• Consider a stimulant medication if appropriate
• Add behavioral strategies or ADHD coaching
• Explore combination therapy

Can I switch from a stimulant to Strattera via telehealth?

Yes. Many people transition from stimulants to non-stimulants for various reasons (side effects, substance concerns, desire for smoother effect). Your provider will create a transition plan, which may involve:

• Gradual stimulant taper
• Overlapping the medications briefly
• Starting Strattera while continuing stimulants until it takes effect

Will my telehealth prescription be accepted at any pharmacy?

Yes. Electronic prescriptions from licensed providers are accepted at all pharmacies. The prescription doesn’t indicate whether your visit was telehealth or in-person. Occasionally, a pharmacy may have questions about a new prescriber—this is routine verification, not rejection.

Can I use telehealth if I live in a rural area with poor internet?

Most telehealth platforms require video capability for ADHD evaluations, which needs reasonably stable internet. However, some accommodations may be possible:

• Using a library, community center, or friend’s internet connection
• Some states allow phone-only visits in limited circumstances
• Mobile data can work if WiFi isn’t available

Contact Klarity’s support team to discuss options for your specific situation.

What happens if I move to a different state?

Providers must be licensed in the state where the patient is physically located during the appointment. If you move:

• Notify your provider immediately
• You’ll likely be transitioned to a provider licensed in your new state
• There may be a brief gap while new provider reviews your records
• State law variations might affect your treatment plan

Klarity operates in multiple states and can often facilitate smooth transfers.

Is telehealth ADHD treatment confidential?

Yes. Telehealth appointments are subject to the same HIPAA privacy protections as in-person visits. Klarity uses encrypted, secure video platforms. To protect your privacy:

• Use a private space for appointments
• Ensure others can’t overhear your conversation
• Don’t use public WiFi without a VPN
• Log out of the patient portal on shared devices

Can I see the same provider for ongoing care?

Yes. Continuity of care is important for ADHD management. Klarity allows you to schedule with the same provider for follow-ups, building a therapeutic relationship over time. Consistent care helps your provider track your progress and make informed treatment adjustments.

Next Steps: Starting Your ADHD Treatment Journey

If you’re struggling with ADHD symptoms and wondering whether telehealth treatment might help, here’s how to move forward:

1. Assess Your Symptoms

Consider whether you experience:

• Difficulty sustaining attention on tasks
• Frequent careless mistakes or overlooking details
• Problems with organization and time management
• Forgetfulness in daily activities
• Difficulty following through on commitments
• Impulsive decision-making
• Restlessness or feeling driven by a motor
• Interrupting others or difficulty waiting your turn

If these symptoms significantly interfere with your work, relationships, or daily functioning, an ADHD evaluation might be appropriate.

2. Gather Your History

Before your appointment, collect:

• School records or report cards showing childhood difficulties
• Work performance reviews
• Any previous mental health evaluations
• Current medication list
• Medical history summary

Don’t let lack of documentation stop you—many people don’t have these records. Your self-report and collateral information (from family members) can suffice.

3. Schedule a Consultation

Choose a reputable telehealth platform like Klarity Health that offers:

• Licensed providers in your state
• Comprehensive diagnostic evaluations
• Clear pricing (insurance or self-pay)
• Ongoing support and medication management
• Easy appointment scheduling

4. Prepare Questions

Write down what you want to know:

• Am I a candidate for non-stimulant medication?
• What’s the difference between treatment options?
• How will we monitor effectiveness?
• What lifestyle changes might help?
• How often will we have follow-up appointments?

5. Be Ready to Commit to Treatment

Effective ADHD management requires:

• Taking medication consistently as prescribed
• Attending regular follow-up appointments
• Communicating openly about symptoms and side effects
• Being patient with the process (especially for non-stimulants)
• Implementing behavioral strategies alongside medication

Conclusion: Accessible, Quality ADHD Care Is Within Reach

For too long, adults with ADHD faced barriers to diagnosis and treatment—long waitlists for psychiatrists, prohibitive costs, and the logistics of frequent office visits. Telehealth has transformed access to ADHD care, and non-stimulant medications like Strattera are among the most accessible treatments because they aren’t subject to the complex regulations governing controlled substances.

Whether you’re newly exploring an ADHD diagnosis or seeking alternatives to stimulant medications, telehealth platforms like Klarity Health offer:

✅ Licensed providers authorized in your state
✅ Comprehensive evaluations meeting diagnostic standards
✅ Flexible scheduling with appointments available within days
✅ Transparent pricing with both insurance and cash options
✅ Ongoing support to optimize your treatment

Don’t let ADHD symptoms continue limiting your potential. Quality, evidence-based treatment is more accessible than ever—often just a few clicks away.

Ready to take the next step? Schedule a consultation with Klarity Health to discuss whether non-stimulant ADHD medication or other treatment options might be right for you. Our compassionate providers are here to help you achieve the focus, organization, and peace of mind you deserve.

References

1. Fierce Healthcare. ‘DEA Finalizes One

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment